Apollo Endosurgery Inc. (APEN)

Name: Apollo Endosurgery Inc. (APEN) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Apollo Endosurgery Inc. (APEN)

Stock Card

$10.00

$0.00 (0.00%)

As on 10-Apr-2023 09:30EDT

Market cap

$580 Mln

Revenue (TTM)

$77 Mln

P/E Ratio

P/B Ratio

9.8

Div. Yield

0 %

Apollo Endosurgery (APEN) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 10.00 High: 10.00

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-30 Mln
ROE

-0.8 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-13.6
Debt to Equity

1.8
Book Value

$0.8
EPS

$-1
Face value

--
Shares outstanding

47,549,200

10 Years Aggregate

CFO

$-181.69 Mln

EBITDA

$-176.08 Mln

Net Profit

$-261.94 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Apollo Endosurgery (APEN)	0.3	0.8	1.2	65.6	66.4	11.7	-30.6
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 10-Apr-2023 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2022	2021	2020	2019	2018	2017	2016
Apollo Endosurgery (APEN)	18.3	147.9	19.3	-17.4	-38.2	-53.9	-30.5
S&P Small-Cap 600	-17.4	25.3	9.6	20.9	-9.7	11.7	24.7
BSE Sensex	4.4	22.0	15.8	14.4	5.9	27.9	1.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Apollo Endosurgery (APEN)

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing... Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas. Read more

CEO, Pres & Director

Mr. Charles S. McKhann
CEO, Pres & Director

Mr. Charles S. McKhann
Headquarters

Austin, TX
Website

https://www.apolloendo.com

FAQs for Apollo Endosurgery (APEN)

What is the current share price of Apollo Endosurgery Inc (APEN) Today?

The share price of Apollo Endosurgery Inc (APEN) is $10.00 (NASDAQ) as of 10-Apr-2023 09:30 EDT. Apollo Endosurgery Inc (APEN) has given a return of 66.41% in the last 3 years.

What is the current PB & PE ratio of Apollo Endosurgery Inc (APEN)?

Since, TTM earnings of Apollo Endosurgery Inc (APEN) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	-10.26	12.54
2021	-10.25	4.13
2020	-3.46	11.58
2019	-2.29	29.53
2018	-1.51	2.39

What is the 52 Week High and Low of Apollo Endosurgery Inc (APEN)?

The 52-week high and low of Apollo Endosurgery Inc (APEN) are Rs -- and Rs -- as of 29-Aug-2026.

What is the market cap of Apollo Endosurgery Inc (APEN)?

Apollo Endosurgery Inc (APEN) has a market capitalisation of $ 580 Mln as on 11-Apr-2023. As per SEBI classification, it is a Small Cap company.

Should I invest in Apollo Endosurgery Inc (APEN)?

Before investing in Apollo Endosurgery Inc (APEN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.